Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Generated Narrative: Group 236947
version: 66; Last updated: 2024-12-14 08:46:28+0000
Artifact Author: Computable Publishing®: MAGIC-to-FEvIR Converter:
Artifact related artifact: No display for RelatedArtifact (type: part-of; resourceReference: ->display: string (PrimitiveType/Group.extension[1].value[x].resourceReference.display): element = string -> display=string[MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes])
url: https://fevir.net/resources/Group/236947
identifier: FEvIR Object Identifier/https://fevir.net/FOI/236947, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-population-group-85394-85798
name: Adults_with_type_2_diabetes
title: Adults with type 2 diabetes and CVD and CKD
status: Active
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
description:
This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
membership: Conceptual